File: /home/govancoz/mail/new/1732061034.M746352P1079873.zacp120.ve.host,S=6690,W=6814
Return-Path: <1004@handeul.co.kr>
Delivered-To: govancoz@zacp120.ve.host
Received: from zacp120.ve.host
by zacp120.ve.host with LMTP
id ySN5K2onPWdBehAAvcbEzQ
(envelope-from <1004@handeul.co.kr>)
for <govancoz@zacp120.ve.host>; Wed, 20 Nov 2024 02:03:54 +0200
Return-path: <1004@handeul.co.kr>
Envelope-to: mike@govan.co.za
Delivery-date: Wed, 20 Nov 2024 02:03:54 +0200
Received: from m11.asadal.net ([121.254.243.200]:45050)
by zacp120.ve.host with smtp (Exim 4.98)
(envelope-from <1004@handeul.co.kr>)
id 1tDYCG-00000004WIT-32cZ
for mike@govan.co.za;
Wed, 20 Nov 2024 02:03:54 +0200
Received: (qmail 14619 invoked by uid 700); 19 Nov 2024 21:51:28 -0000
Received: from unknown (HELO ?192.168.1.17?) (1004@handeul.co.kr@197.232.126.205)
by 0 (qmail 1.03 + ejcp) with SMTP;
20 Nov 2024 06:51:28 +0900
Content-Type: multipart/alternative; boundary="===============0286766850=="
MIME-Version: 1.0
Subject: PROPOSED BUSINESS PARTNERSHIP.
To: Recipients <1004@handeul.co.kr>
From: "Dr. Yuichi Tamura" <1004@handeul.co.kr>
Date: Wed, 20 Nov 2024 00:51:09 +0300
Reply-To: dr.tamurapharm@gmail.com
X-Spam-Status: No, score=4.0
X-Spam-Score: 40
X-Spam-Bar: ++++
X-Ham-Report: Spam detection software, running on the system "zacp120.ve.host",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: I hope you're well. Nichi-Iko Pharmaceutical Co., Ltd., a
leading Japanese generics company, is seeking a representative in South Africa
for mineral procurement and to establish an annex office. This [...]
Content analysis details: (4.0 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[121.254.243.200 listed in sa-trusted.bondedsender.org]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to
Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[121.254.243.200 listed in bl.score.senderscore.com]
0.0 RCVD_IN_VALIDITY_SAFE_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to
Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[121.254.243.200 listed in sa-accredit.habeas.com]
0.0 KAM_DMARC_STATUS Test Rule for DKIM or SPF Failure with Strict
Alignment
0.5 SUBJ_ALL_CAPS Subject is all capitals
0.0 HTML_MESSAGE BODY: HTML included in message
1.0 KAM_LAZY_DOMAIN_SECURITY Sending domain does not have any
anti-forgery methods
2.5 FREEMAIL_FORGED_REPLYTO Freemail in Reply-To, but not From
X-Spam-Flag: NO
You will not see this in a MIME-aware mail reader.
--===============0286766850==
Content-Type: text/plain; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
I hope you're well.
Nichi-Iko Pharmaceutical Co., Ltd., a leading Japanese generics company, i=
s seeking a representative in South Africa for mineral procurement and to e=
stablish an annex office. This is a five-year contract with a strategic par=
tnership opportunity.
Please reply if interested for more details.
Best regards,
Dr. Yuichi Tamura
President & CEO
--===============0286766850==
Content-Type: text/html; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Diso-8859-1"/></head><BODY><P style=3D"FONT-SIZE: small; FONT-FAMILY: Ari=
al, Helvetica, sans-serif; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRA=
NSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(34,34,34); FONT-STYLE: normal; O=
RPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(255,255=
,255); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps:=
normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial=
; text-decoration-style: initial; text-decoration-color: initial">I hope yo=
u're well.</P>
<P style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; WH=
ITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 40=
0; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-=
SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 0px; font=
-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-=
width: 0px; text-decoration-thickness: initial; text-decoration-style: init=
ial; text-decoration-color: initial">Nichi-Iko Pharmaceutical Co., Ltd., a =
leading Japanese generics company, is seeking a representative in South Afr=
ica for mineral procurement and to establish an annex office. This is a fiv=
e-year contract with a strategic partnership opportunity.</P>
<P style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; WH=
ITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 40=
0; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-=
SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 0px; font=
-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-=
width: 0px; text-decoration-thickness: initial; text-decoration-style: init=
ial; text-decoration-color: initial">Please reply if interested for more de=
tails.</P>
<P style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; WH=
ITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 40=
0; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-=
SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 0px; font=
-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-=
width: 0px; text-decoration-thickness: initial; text-decoration-style: init=
ial; text-decoration-color: initial">Best regards,<BR>Dr. Yuichi Tamura<BR>=
President & CEO</P></BODY></HTML>
--===============0286766850==--